FindMyKOL
Clinical trialNCT07115901Active, not recruitingInterventional

Guaranteed Income to Boost HIV Care Continuity and Suppression Post-Jail Release

NCT07115901 is an interventional trial sponsored by University of California, San Francisco. As of 21 Nov 2026, it is active and no longer recruiting. It studies HIV (Human Immunodeficiency Virus). The registry lists an enrollment of 33 participants at 1 site in 1 country. The registry lists a start date of 1 Dec 2025 and a primary completion date of 25 Feb 2027.

SponsorUniversity of California, San Francisco →Enrollment33HIV (Human Immunodeficiency Virus)
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT07115901
FieldValue
Registry IDNCT07115901
StatusActive not recruiting
Study typeInterventional trial
Lead sponsorUniversity of California, San Francisco
Enrollment33
Registered sites1
Countries1
ConditionsHIV (Human Immunodeficiency Virus)
Start1 Dec 2025
Primary completion25 Feb 2027
Study completion25 Feb 2027
Last update posted9 Jun 2026

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The goal of this clinical trial is to understand the implementation requirements and potential health impacts of a guaranteed income (GI) intervention targeting people living with HIV with criminal legal involvement (PWH-CLI). The main questions it aims to answer are: * How acceptable is a GI intervention, and its intervention components, among PWH-CLI participants and stakeholders? * How feasible is a GI intervention for PWH-CLI? What are the implementation barriers and opportunities for this intervention? * What is the preliminary efficacy of the GI intervention on improving HIV care outcomes for PWH-CLI? Researches will compare study engagement and study outcomes across three randomization arms (A: receive full GI amount as one lump sum payment; B: receive full GI amount split over nine monthly installments; C: participant chooses whether to receive GI as lump sum payment or monthly installments). HIV care outcomes will be compared against a retrospective cohort of PWH-CLI patients as historical controls. Participants will: * Be randomized to receive GI intervention as a lump sum payment or monthly installment (over nine months) or choose their preference. * Complete 3 surveys throughout study follow up to assess experience with the intervention, experience with social services and benefits programs, experience with the criminal legal system, and HIV care outcomes. * Be interviewed by the research team to further understand the experience with the intervention.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

California, United States1 site
  • University of California, San Francisco

    San Francisco

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCalifornia: 1 siteCA1NevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT07115901

Each answer restates registry values shown on this page.

What is NCT07115901?

NCT07115901 is an interventional trial sponsored by University of California, San Francisco. It studies HIV (Human Immunodeficiency Virus).

Is NCT07115901 recruiting?

As of 21 Nov 2026, it is active and no longer recruiting.

Who leads NCT07115901?

The registry names Paul D Wesson, PhD (principal investigator, University of California, San Francisco) as the overall official.

Where does NCT07115901 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When is NCT07115901 expected to complete?

The registry lists a primary completion date of 25 Feb 2027 and a study completion date of 25 Feb 2027. The sponsor last updated the record on 9 Jun 2026.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.